Study Title | Study Dates | Sponsor | Status | Primary Investigator(s) | Other Investigator(s) | ||
---|---|---|---|---|---|---|---|
COMPARE-VOE | 04/01/2019 to - | Duke University - NHLBI/NIH | Recruiting |
Gentry Wilkerson |
Sarah Dubbs |
||
Description: A phase III randomized single blinded study that aims to compare the two analgesic protocols recommended by the NHLBI for treating Vaso-occlusive episodes in the Emergency Department. Clinicaltrials.gov ID: NCT03933397 |
Keywords: Sickle Cell Disease, Vaso-occlusive episodes, Acute pain crisis, Opioid, Analgesia |
||||||
CEPHEID | 09/01/2018 to - | Cepheid | Recruiting |
Gentry Wilkerson |
|||
Description: A prospective, nonblinded, randomized controlled trial that aims to assess whether an FDA-approved rapid turnaround test (RTAT) for Neisseria gonorrheae and Chlamydia trachomatis infections will lead to more appropriate antibiotic prescription in the emergency department. Clinicaltrials.gov ID: NCT03098394 |
Keywords: Sexually Transmitted Disease, Sexually Transmitted Infection, STD, Gonorrhea, Chlamydia, Rapid Turnaround Test, Vaginal Discharge |
||||||
BLD-2660 | 05/04/2020 to - | Blade Therapeutics, Inc | Completed |
Gentry Wilkerson |
|||
Description: A Phase 2 randomized, double-blinded, placebo-controlled multicenter study designed to evaluate BLD-2660 as add-on to standard of care (SOC) therapy in hospitalized subjects with recently diagnosed COVID-19 compared to SOC treatment. The study will include a Screening period, a Treatment period, and a Follow-up period.
Clinicaltrials.gov ID: NCT04334460 |
Keywords: SARS-CoV-2, COVID-19, Calpain, Calpain inhibitors |
||||||
Percutaneous Ultrasound Gastrostomy technique | 08/01/2019 to - | CoapTech | Recruiting |
Gentry Wilkerson |
Michael McCurdy Daniel Haase Kami Windsor WanTsu Wendy Chang |
||
Description: A single-center, non-randomized, non-blinded feasibility study to evaluate the performance, safety and tolerability of the Percutaneous Ultrasound Gastrostomy (PUG) procedure that utilizes a novel device in conjunction with widely available ultrasound technology. Clinicaltrials.gov ID: NCT03956277 |
Keywords: Gastrostomy, Percutaneous Ultrasound Gastrostomy, PUG, Feeding tube |
||||||
DIAMOND | 01/01/2018 to - | Janssen Research & Development, LLC | Terminated |
Gentry Wilkerson |
Mike Winters |
||
Description: A multi-centered, double blinded clinical trial to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment in participants with Influenza A who are at risk of developing complications.
Clinicaltrials.gov ID: NCT03381196 |
Keywords: Influenza A, Upper Respiratory Tract infection, URI, Pimodivir |
||||||
SAPPHIRE | 01/01/2018 to - | Janssen Research & Development, LLC | Terminated |
Gentry Wilkerson |
Mike Winters |
||
Description: A multi-centered, double blinded clinical trial to evaluate the efficacy/safety of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment in hospitalized participants with Influenza A. Clinicaltrials.gov ID: NCT03376321 |
Keywords: Influenza A, Upper Respiratory Tract infection, URI, Pimodivir |
||||||
COVID Home SpO2 | 05/18/2020 to - | N/A | Completed |
Gentry Wilkerson |
Angela Smedley Christy Carter |
||
Description: A prospective, non blinded, non randomized trial conducted at the University of Maryland Medical Center Downtown Campus (UMMC) located in Baltimore, Maryland that aims to evaluate patient engagement in a program to monitor home pulse oximetry and development of symptoms for patients with or under investigation for infection with SARS-CoV-2. |
Keywords: SARS-CoV-2, COVID-19, Pulse Oximetry, Pulse Oximeter |
||||||
REGENERON 2067 | 10/01/2020 to - | Regeneron Pharmaceuticals | Recruiting |
Gentry Wilkerson |
|||
Description: A randomized, double-blinded, placebo-controlled, adaptive phase 1/2/3 master protocol will assess the safety, tolerability, and efficacy of REGN10933+REGN10987 and REGN10989 in ambulatory patients with COVID-19. The multicenter conduct of this study will enable generalizable evidence of the safety, tolerability, and efficacy of these investigational mAbs for COVID-19. Clinicaltrials.gov ID: NCT04425629 |
Keywords: SARS-CoV-2, COVID-19, Regeneron, SPIKE, Anti-SPIKE, Monoclonal Antibody |